Director Thomas R. Tyrrell executed a sale of 500 shares of Chemung Financial Corporation common stock on February 2, 2026, at a price of $61.00 per share. The transaction, which totaled $30,500, was reported in a Form 4 filed with the Securities and Exchange Commission.
At the time of the transaction, shares of CHEMUNG FINANCIAL CORP (NASDAQ:CHMG) were trading close to their 52-week high of $61.58 and were quoted at $62.22. Following the disposition, Tyrrell retains direct ownership of 8,799.873 shares, a figure that includes dividends reinvested under the issuer's Dividend Reinvestment Plan.
The Form 4 filing was signed by Kathleen S. McKillip in her capacity as Attorney-in-Fact, pursuant to a Power of Attorney dated 6/25/2025. The filing discloses the exact transaction details and Tyrrell's remaining shareholdings as reported to the SEC.
Chemung Financial remains a consistent dividend payer. The company has maintained dividend distributions for 52 consecutive years. Its current annual dividend is $1.36 per share, representing a dividend yield of 2.24 percent. Separately, the board of directors approved a quarterly cash dividend of $0.34 per share that will be payable on January 2, 2026, to shareholders of record as of December 19, 2025. The dividend approval was announced through a company press release. The release did not include any further updates on earnings, merger activity, or changes to analyst ratings.
Market performance for CHMG has been notable in recent months. Over the past six months the stock has delivered a price return of 25.18 percent. According to InvestingPro analysis cited in the company's information, Chemung Financial's shares appear slightly undervalued when measured against a Fair Value assessment; the analysis also references additional proprietary tips available to subscribers.
Summary of the transaction and company disclosures
- Insider sale: 500 shares sold on February 2, 2026, at $61.00 per share, netting $30,500.
- Post-transaction holdings: Tyrrell owns 8,799.873 shares, inclusive of dividends reinvested under the DRIP.
- Regulatory filing: Sale reported on a Form 4 signed by Kathleen S. McKillip under POA dated 6/25/2025.
The company continues to signal stability in its capital return policy through a long-running dividend streak and a newly approved quarterly payout. No additional commentary on corporate strategy, earnings guidance, or analyst revisions was provided in the most recent company communication.